Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学BRAF Tumor-Agnostic

Zev Wainberg

MD

🏢UCLA Jonsson Comprehensive Cancer Center🌐USA

Professor of Medicine and Co-Director of GI Oncology

65
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Zev Wainberg contributed to the ROAR basket trial and related studies supporting the tumor-agnostic approval of dabrafenib plus trametinib for BRAF V600E mutant solid tumors including rare histologies. His work expanded BRAF-targeted therapy beyond melanoma and colorectal cancer. He advances precision GI oncology and basket trial methodology.

Share:

🧪Research Fields 研究领域

dabrafenib plus trametinib BRAF V600E agnostic
ROAR basket trial
BRAF-mutant rare tumors
pan-tumor BRAF
precision GI oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Zev Wainberg 的研究动态

Follow Zev Wainberg's research updates

留下邮箱,当我们发布与 Zev Wainberg(UCLA Jonsson Comprehensive Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment